Related Experiment Video

Updated: Jul 2, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

mgrA regulates staphylococcal virulence important for induction and progression of septic arthritis and sepsis

Ing-Marie Jonsson1, Catharina Lindholm, Thanh T Luong

  • 1Department of Rheumatology and Inflammation Research, Göteborg University, Göteborg, Sweden. ing-marie.jonsson@rheuma.gu.se

Microbes and Infection
|August 12, 2008
PubMed

Insights

The mgrA gene in Staphylococcus aureus significantly impacts the severity of septic arthritis and sepsis. Deleting mgrA reduced disease severity and mortality in mice, indicating its crucial role in staphylococcal infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Staphylococcal infections, including septic arthritis and sepsis, pose significant health risks.
  • Increasing antibiotic resistance in staphylococci necessitates research into virulence factors.
  • Global regulatory genes like agr and sarA control Staphylococcus aureus virulence.

Purpose of the Study:

  • To investigate the role of the global regulator MgrA in the pathogenesis of septic arthritis and sepsis.
  • To assess the impact of mgrA gene expression on disease induction and progression.

Main Methods:

  • Utilized a mouse model of septic arthritis and sepsis.
  • Compared the effects of wild-type Staphylococcus aureus and an mgrA mutant strain.
  • Monitored disease severity, weight development, survival rates, and bacterial persistence in kidneys.

Main Results:

  • Mice infected with the mgrA mutant showed significantly reduced arthritis severity and better weight development.
  • Complete survival (100%) was observed in mice inoculated with the mgrA mutant, versus 70% mortality in the wild-type group (p=0.003).
  • The mgrA mutant exhibited significantly less bacterial persistence in the kidneys compared to the wild-type strain.

Conclusions:

  • The mgrA gene plays a critical role in regulating virulence factors essential for the establishment and progression of septic arthritis and sepsis.
  • MgrA is a key determinant of Staphylococcus aureus virulence in systemic infections.
  • Targeting MgrA could be a potential strategy for combating severe staphylococcal diseases.

More Related Videos

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues07:10

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues

Published on: February 19, 2019

Related Concept Videos

Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...